172 related articles for article (PubMed ID: 3259500)
1. [2 phenotypic variants of B-cell lymphocytic leukemia].
Merson AG; Brosh'e Zh; Gipsh NM; Karminskaia NM; Udris OIu
Eksp Onkol; 1988; 10(1):40-3. PubMed ID: 3259500
[TBL] [Abstract][Full Text] [Related]
2. Surface immunoglobulin intensivity and p67 (CD5) antigen expression define different forms of B-cell chronic lymphocytic leukaemia.
Bassan R; Pronesti M; Buzzetti M; Viero P; Minetti B; Comotti B; Buelli M; Barbui T
Haematologica; 1987; 72(3):221-5. PubMed ID: 3114087
[No Abstract] [Full Text] [Related]
3. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
4. Surface phenotype and clinical stages in B-cell chronic lymphocytic leukaemia.
Orfao A; Gonzalez M; San Miguel JF; Moro MJ; Fernandez-Calvo J; Carnero M; Galindo P; Lopez Borrasca A
Haematologica; 1987; 72(1):39-43. PubMed ID: 3108093
[No Abstract] [Full Text] [Related]
5. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
Rak K; Pecze K; Kiss A; Telek B
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
[TBL] [Abstract][Full Text] [Related]
6. Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.
Brown VA; Smith SK; Dewar AE; Stockdill G; Maddy AH
Clin Exp Immunol; 1985 Oct; 62(1):95-103. PubMed ID: 3877584
[TBL] [Abstract][Full Text] [Related]
7. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
9. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia.
Kettman JR; Smith RG; Uhr JW; Vitetta ES; Sheehan R; Ligler FS; Frenkel EP
Blood Cells; 1983; 9(1):21-33. PubMed ID: 6407550
[TBL] [Abstract][Full Text] [Related]
10. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
11. Interindividual phenotypic variations in CLL B lymphocyte maturation indication of different maturation blocks.
Rozynkowa D; Antosz H; Rupniewska ZM; Kurowska M; Kulig A; Welcz B; Gorski G; Wojcierowski J
Acta Anthropogenet; 1985; 9(1-3):48-62. PubMed ID: 3939670
[TBL] [Abstract][Full Text] [Related]
12. Relationship between different cell surface markers in chronic lymphocytic leukemia.
Potomski J; Harłozińska A; Becker M; Noworolska A
Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
[TBL] [Abstract][Full Text] [Related]
13. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
14. Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type.
Herrmann F; Lochner A; Philippen H; Jauer B; Rühl H
Clin Exp Immunol; 1982 Jul; 49(1):157-62. PubMed ID: 6982129
[TBL] [Abstract][Full Text] [Related]
15. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells.
Bergui L; Tesio L; Schena M; Riva M; Malavasi F; Schulz T; Marchisio PC; Caligaris-Cappio F
Eur J Immunol; 1988 Jan; 18(1):89-96. PubMed ID: 3278912
[TBL] [Abstract][Full Text] [Related]
16. Immunological definition of leukemic cell surface phenotypes.
Melvin SL
Cancer Res; 1981 Nov; 41(11 Pt 2):4790-3. PubMed ID: 6975161
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
18. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
